CASP9 and Alzheimer disease: Western blot analysis demonstrate that Caspase-9 levels were significantly elevated in the GPR43-OE group (1.40 ± 0.10) compared to the AD model group (1.75 ± 0.09; p < 0.05; Fig. 6B).